CDC Website CDC Website

To Join the NPIN community or

You are here

HIV/AIDS

Conference for Early Stage HIV/AIDS Vaccine Researchers (R13)

This Funding Opportunity Announcement (FOA) encourages Research Conference Grant (R13) applications to conduct intensive workshop/conference/meeting(s) that address the needs of early stage HIV/AIDS vaccine researchers as they translate preclinical research from nonhuman primates (NHPs) to human clinical trials.

Elton John AIDS Foundation 2016 Grants

For this 2016 funding round, as in previous years, the Elton John AIDS Foundation (EJAF) invites letters of intent (LOIs) from any proposed project that is working with people who are most affected by HIV in the Americas, defined as the United States, Canada, Mexico, the Caribbean, or Central or South America.

Resilient and Responsive Health Systems (RRHS) Initiative

Supported through the President’s Emergency Plan for AIDS Relief (PEPFAR), the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is accepting applications for fiscal year (FY) 2017 in support of the Resilient and Responsive Health Systems (RRHS) Initiative. The purpose of this initiative is to address fundamental health systems constraints that impede the availability of and access to quality health services related to HIV, other infectious diseases and priority health areas in the Democratic Republic of Congo (DRC), Liberia, Sierra Leone, and South Sudan.

Silencing of HIV-1 Proviruses (R61/R33)

This Funding Opportunity Announcement (FOA) encourages Exploratory and developmental bi-phasic research applications to support the identification and optimization of small molecules or RNAs that interact with host epigenetic machinery to mediate long-term or permanent epigenetic silencing of HIV-1 proviruses.

Limited Interaction Targeted Epidemiology (LITE) to Advance HIV Prevention (UG3/UH3)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to use innovative technology to conduct epidemiologic studies of large cohorts of U.S. populations at high risk of HIV infection: men who have sex with men (MSM), transgender women, and black/African American women. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. Funding for a UG3 phase will be used to enroll and follow sufficient numbers of high-risk HIV-negative participants to reach seroconversion milestone targets.

Pages

Subscribe to RSS - HIV/AIDS